Delivery Order SPE2DB22D2007-SPE2DB25FJ2DL

Award Date 6/9/25
Potential Completion Date 6/10/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,561.94 firm-fixed-price delivery order is for the supply of 130 mg/mL vials of the drug Phenobarbital. The contract has an ultimate completion date of June 5, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Phenobarbital 130 mg/ml vials, a medication used for various medical conditions. The contract has a firm fixed price of $5,283.68 and a performance period ending on May 12, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 130 mg/ml vials of the pharmaceutical product Phenobarbital. The $3,172.24 contract has a performance period through February 12, 2024 and does not include any set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical with a potential value of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,016.80, is for the delivery of 4,567,949,101 milliliters of Phenobarbital 130 mg/ml vials. The contract has an ultimate completion date of April 18, 2025 and was awarded on April 17, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4568161338 - Phenobarbital 65 mg/ml vial. The $3,905.64 firm fixed-price contract has a completion date of May 7, 2025. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PHENOBARBITAL 130 MG/ML VIALML. The contract has a firm fixed price of $4,262.54 and a period of performance through March 28, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,006.47 firm fixed price delivery order is for the supply of 4565012904 Phenobarbital 65 mg/mL vials. Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,938.32 fixed-price delivery order is for the supply of Phenobarbital 130 mg/mL vials. This award is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to...
This federal contract award is a $2,339.82 Firm Fixed Price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 130 mg/ml vials of Phenobarbital, a medication commonly used to treat seizures and certain types of brain disorders. This contract is not set-aside and is awarded as an open competition. Amerisourcebergen Drug Corp holds a substantial...
This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Phenobarbital 130 mg/ml vials to the Defense Logistics Agency (DLA) Troop Support Medical. The $4,417.38 firm fixed price delivery order (SPE2DB24FL2NU) has an ultimate completion date of August 16, 2024 and is not designated as a set-aside. AmerisourceBergen also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FJ2DL
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,404.08 firm fixed-price contract is for the delivery of Phenobarbital 130 mg/ml vials. The contract has an ultimate completion date of June 10, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is not set aside and is part of the company's broader work supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 9/14/25, 12:57 AM